Michael J. Coyle's most recent trade in Haemonetics Corp. was a trade of 2,693 Common Stock done . Disclosure was reported to the exchange on July 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Haemonetics Corp. | Michael J. Coyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 2,693 | 15,394 (0%) | 0% | - | Common Stock | |
| Integer Holdings Corp | Michael J. Coyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 1,355 | 1,355 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Michael J. Coyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,207 | 12,701 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Michael J. Coyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 2,226 | 10,494 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Michael J. Coyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,730 | 8,268 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Michael J. Coyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 3,077 | 5,538 (0%) | 0% | - | Common Stock | |
| iRhythm Technologies Inc | Michael J. Coyle | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 33,247 | 33,247 (0%) | 0% | 0 | Common Stock | |
| Heartland Financial USA, Inc. | Michael J. Coyle | EVP Senior General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Jan 2021 | 97 | 97 | - | - | 2018 Time-Based Restricted Stock | |
| Heartland Financial USA, Inc. | Michael J. Coyle | EVP Senior General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.37 per share. | 04 Jan 2021 | 97 | 11,279 (0%) | 0% | 40.4 | 3,916 | Common Stock |
| Heartland Financial USA, Inc. | Michael J. Coyle | EVP Senior General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 04 Jan 2021 | 66 | 66 | - | - | 2018 Performance Based Restricted Stock (1-year performance) | |
| Heartland Financial USA, Inc. | Michael J. Coyle | EVP Senior General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.36 per share. | 04 Jan 2021 | 66 | 11,345 (0%) | 0% | 40.4 | 2,664 | Common Stock |
| Medtronic | Michael J. Coyle | EVP & Group Pres, Cardiac&Vasc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.13 per share. | 03 Nov 2020 | 393 | 190,390 (0%) | 0% | 103.1 | 40,530 | Ordinary Shares |
| Medtronic | Michael J. Coyle | EVP & Group Pres, Cardiac&Vasc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2020 | 21,164 | 21,164 | - | - | Performance Share Units |